Compositions and methods comprising antibodies that bind to covalent peptide conjugates
US12391770B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Feb 23, 2024 |
| Grant date | Aug 19, 2025 |
| Priority date | — |
| Expiry date | Feb 23, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are compositions and methods that include binding partners that bind with specificity to target sites on proteins or peptides that comprise a covalently attached molecule. The binding partners are provided as antibodies and antibody derivatives that specifically bind to proteins and peptides that have been covalently modified by attachment of a molecule, such as a drug. The binding partners can bind with specificity to covalently modified peptides when presented in the context of a major histocompatibility complex (MHC). Uses of the compositions and methods for prophylaxis or therapy of disorders are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.